VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume

Posted by Max Byerly on Apr 29th, 2024

VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 137,325 shares were traded during trading, an increase of 4% from the previous session’s volume of 132,308 shares.The stock last traded at $87.21 and had previously closed at $86.80.

VanEck Pharmaceutical ETF Stock Performance

The stock has a 50 day moving average price of $88.64 and a 200 day moving average price of $83.72. The company has a market cap of $500.07 million, a P/E ratio of 20.57 and a beta of 0.72.

VanEck Pharmaceutical ETF Announces Dividend

The business also recently announced a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were given a dividend of $0.5328 per share. The ex-dividend date of this dividend was Monday, April 1st.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Allworth Financial LP purchased a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at $28,000. Global Retirement Partners LLC grew its holdings in shares of VanEck Pharmaceutical ETF by 2,343.8% during the first quarter. Global Retirement Partners LLC now owns 391 shares of the company’s stock valued at $35,000 after buying an additional 375 shares in the last quarter. Cary Street Partners Investment Advisory LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the third quarter valued at $60,000. CoreFirst Bank & Trust purchased a new position in shares of VanEck Pharmaceutical ETF during the third quarter valued at $76,000. Finally, Assetmark Inc. purchased a new position in shares of VanEck Pharmaceutical ETF during the third quarter valued at $211,000.

VanEck Pharmaceutical ETF Company Profile

(Get Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.